Zimmermann Martine bought CADL
September 8, 2026 · Form 4 insider transaction
Zimmermann Martine bought 64,000 shares of Candel Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
64,000
Price
$0.00
Total value
N/A
InsiderZimmermann Martine
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 8, 2026
Filing dateSeptember 10, 2026
Shares owned after64,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying this option shall vest and become exercisable in thirty-six (36) equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.